This Article Full Text Full Text (PDF) All Versions of this Article: 97/2/125    most recent 01.RES.0000174614.74469.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez-Vita, J. Articles by Egido, J. Search for Related Content PubMed PubMed Citation Articles by Rodriguez-Vita, J. Articles by Egido, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cell signalling/signal transduction Growth factors/cytokines Hypertension - basic studies Mechanism of atherosclerosis/growth factors Other Vascular biology

(Circulation Research. 2005;97:125.)
© 2005 American Heart Association, Inc.

Molecular Medicine

Endothelin-1, via ET_A Receptor and Independently of Transforming Growth Factor-ß, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells

Juan Rodriguez-Vita, Marta Ruiz-Ortega, Mónica Rupérez, Vanessa Esteban, Elsa Sanchez-López, Juan José Plaza, Jesús Egido

From the Vascular and Renal Research Laboratory, Fundación Jiménez Diaz, Universidad Autónoma Madrid, Spain

Correspondence to Marta Ruiz-Ortega, PhD, Vascular and Renal Research Laboratory, Universidad Autónoma Madrid, Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, 28040 Madrid, Spain. E-mail mruizo{at}fjd.es

Endothelin (ET)-1 is a potent vasoconstrictor that participates in cardiovascular diseases. Connective tissue growth factor (CTGF) is a novel fibrotic mediator that is overexpressed in human atherosclerotic lesions, myocardial infarction, and experimental models of hypertension. In vascular smooth muscle cells (VSMCs), CTGF regulates cell proliferation/apoptosis, migration, and extracellular matrix (ECM) accumulation. Our aim was to investigate whether ET-1 could regulate CTGF and to investigate the potential role of ET-1 in vascular fibrosis. In growth-arrested rat VSMCs, ET-1 upregulated CTGF mRNA expression, promoter activity, and protein production. The blockade of CTGF by a CTGF antisense oligonucleotide decreased FN and type I collagen expression in ET-1–treated cells, showing that CTGF participates in ET-1–induced ECM accumulation. The ET_A, but not ET_B, antagonist diminished ET-1–induced CTGF expression gene and production. Several intracellular signals elicited by ET-1, via ET_A receptors, are involved in CTGF synthesis, including activation of RhoA/Rho-kinase and mitogen-activated protein kinase and production of reactive oxygen species. CTGF is a mediator of TGF-ß– and angiotensin (Ang) II–induced fibrosis. In VSMCs, ET-1 did not upregulate TGF-ß gene or protein. The presence of neutralizing transforming growth factor (TGF)-ß antibody did not modify ET-1–induced CTGF production, showing a TGF-ß–independent regulation. We have also found an interrelationship between Ang II and ET-1 because the ET_A antagonist diminished CTGF upregulation caused by Ang II. Collectively, our results show that, in cultured VSMCs, ET-1, independently of TGF-ß and through the activation of several intracellular signals via ET_A receptors, regulates CTGF. This novel finding suggests that CTGF could be a mediator of the profibrotic effects of ET-1 in vascular diseases.

Key Words: endothelin-1 • connective tissue growth factor • signal transduction • vascular smooth muscle cells • extracellular matrix

This article has been cited by other articles:

				A Valentin, L Cardamone, S Baek, and J.D Humphrey Complementary vasoactivity and matrix remodelling in arterial adaptations to altered flow and pressure J R Soc Interface, March 6, 2009; 6(32): 293 - 306. [Abstract] [Full Text] [PDF]

				J. D. Humphrey Mechanisms of Arterial Remodeling in Hypertension: Coupled Roles of Wall Shear and Intramural Stress Hypertension, August 1, 2008; 52(2): 195 - 200. [Full Text] [PDF]

				F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]

				A. P. Gomez, M. J. Moreno, A. Iglesias, P. X. Coral, and A. Hernandez Endothelin 1, its Endothelin Type A Receptor, Connective Tissue Growth Factor, Platelet-Derived Growth Factor, and Adrenomedullin Expression in Lungs of Pulmonary Hypertensive and Nonhypertensive Chickens Poult. Sci., May 1, 2007; 86(5): 909 - 916. [Abstract] [Full Text] [PDF]

				M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-{beta} signaling in vascular fibrosis Cardiovasc Res, May 1, 2007; 74(2): 196 - 206. [Abstract] [Full Text] [PDF]

				C. Castanares, M. Redondo-Horcajo, N. Magan-Marchal, P. ten Dijke, S. Lamas, and F. Rodriguez-Pascual Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation J. Cell Sci., April 1, 2007; 120(7): 1256 - 1266. [Abstract] [Full Text] [PDF]

				F. Milliat, A. Francois, M. Isoir, E. Deutsch, R. Tamarat, G. Tarlet, A. Atfi, P. Validire, J. Bourhis, J.-C. Sabourin, et al. Influence of Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation: Implication in Radiation-Induced Vascular Damages Am. J. Pathol., October 1, 2006; 169(4): 1484 - 1495. [Abstract] [Full Text] [PDF]